Free Trial

Barrington Research Weighs in on Cinemark FY2025 Earnings

Cinemark logo with Consumer Discretionary background
Remove Ads

Cinemark Holdings, Inc. (NYSE:CNK - Free Report) - Stock analysts at Barrington Research lowered their FY2025 EPS estimates for shares of Cinemark in a report issued on Monday, March 24th. Barrington Research analyst P. Sholl now forecasts that the company will post earnings per share of $1.29 for the year, down from their prior estimate of $1.38. Barrington Research currently has a "Outperform" rating and a $40.00 target price on the stock. The consensus estimate for Cinemark's current full-year earnings is $1.93 per share. Barrington Research also issued estimates for Cinemark's FY2026 earnings at $1.89 EPS and FY2027 earnings at $2.05 EPS.

Cinemark (NYSE:CNK - Get Free Report) last issued its quarterly earnings data on Wednesday, February 19th. The company reported $0.33 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.39 by ($0.06). Cinemark had a return on equity of 65.83% and a net margin of 10.16%. The company had revenue of $814.30 million for the quarter, compared to analyst estimates of $797.18 million. During the same quarter last year, the business earned ($0.15) earnings per share. The company's revenue was up 27.5% on a year-over-year basis.

Several other research analysts have also recently weighed in on the company. Wells Fargo & Company lowered their price objective on Cinemark from $38.00 to $36.00 and set an "overweight" rating on the stock in a research report on Wednesday, January 29th. Benchmark lowered their target price on shares of Cinemark from $40.00 to $35.00 and set a "buy" rating on the stock in a report on Thursday, February 20th. Morgan Stanley cut their price target on Cinemark from $40.00 to $35.00 and set an "overweight" rating for the company in a research note on Thursday, February 20th. JPMorgan Chase & Co. reduced their price target on Cinemark from $31.00 to $30.00 and set a "neutral" rating on the stock in a research report on Thursday, February 20th. Finally, Macquarie reaffirmed an "outperform" rating and issued a $35.00 price objective on shares of Cinemark in a report on Thursday, February 20th. One analyst has rated the stock with a sell rating, four have issued a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, Cinemark has a consensus rating of "Moderate Buy" and a consensus target price of $32.70.

Remove Ads

Get Our Latest Stock Report on Cinemark

Cinemark Stock Performance

CNK traded down $0.92 during trading on Wednesday, hitting $24.82. The stock had a trading volume of 2,382,732 shares, compared to its average volume of 2,910,945. The company has a 50 day moving average price of $27.54 and a 200-day moving average price of $29.40. The firm has a market cap of $3.04 billion, a price-to-earnings ratio of 12.22 and a beta of 2.41. Cinemark has a one year low of $16.32 and a one year high of $36.28. The company has a debt-to-equity ratio of 3.28, a current ratio of 1.01 and a quick ratio of 0.96.

Institutional Investors Weigh In On Cinemark

A number of institutional investors have recently made changes to their positions in CNK. Elequin Capital LP boosted its holdings in Cinemark by 211.6% in the fourth quarter. Elequin Capital LP now owns 997 shares of the company's stock valued at $31,000 after acquiring an additional 677 shares during the last quarter. Russell Investments Group Ltd. increased its position in shares of Cinemark by 402.4% during the fourth quarter. Russell Investments Group Ltd. now owns 1,030 shares of the company's stock worth $32,000 after buying an additional 825 shares during the period. Quarry LP raised its stake in Cinemark by 714.8% during the third quarter. Quarry LP now owns 1,491 shares of the company's stock worth $42,000 after buying an additional 1,308 shares during the last quarter. Aster Capital Management DIFC Ltd boosted its position in Cinemark by 380.0% during the fourth quarter. Aster Capital Management DIFC Ltd now owns 1,896 shares of the company's stock valued at $59,000 after acquiring an additional 1,501 shares during the last quarter. Finally, R Squared Ltd acquired a new stake in Cinemark during the 4th quarter worth about $63,000.

Insider Activity at Cinemark

In other Cinemark news, insider Wanda Marie Gierhart sold 9,119 shares of the company's stock in a transaction dated Tuesday, February 25th. The stock was sold at an average price of $27.00, for a total value of $246,213.00. Following the completion of the transaction, the insider now owns 147,414 shares of the company's stock, valued at $3,980,178. This represents a 5.83 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 2.30% of the stock is currently owned by insiders.

Cinemark Announces Dividend

The business also recently declared a -- dividend, which was paid on Wednesday, March 19th. Stockholders of record on Wednesday, March 5th were paid a $0.08 dividend. The ex-dividend date was Wednesday, March 5th. Cinemark's payout ratio is currently 15.76%.

About Cinemark

(Get Free Report)

Cinemark Holdings, Inc, together with its subsidiaries, engages in the motion picture exhibition business. As of February 16, 2024, it operated 501 theatres with 5,719 screens in 42 states and 13 countries in South and Central America. Cinemark Holdings, Inc was founded in 1984 and is headquartered in Plano, Texas.

Further Reading

Earnings History and Estimates for Cinemark (NYSE:CNK)

Should You Invest $1,000 in Cinemark Right Now?

Before you consider Cinemark, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cinemark wasn't on the list.

While Cinemark currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

3 Bank Stocks Defying Market Turmoil—Cheap Options Trades!
Time to Buy SoFi? Fintech’s Next Big Move
3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads